Edwards Stock Today

<div class='circular--portrait' style='background:#CD0D74;color: white;font-size:4em;padding-top: 25px;;'>EW</div>


0 / 100

Odds of Distress

Analyze Filter   Earning Report: April 28, 2020
Equity ratings for Edwards Lifesciences Corporatio are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting January 3, 2020 and ending today April 2, 2020. Click here to learn more.

Edwards Lifesciences Profile

Upcoming quarterly earning report is expected on April 28, 2020. Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 13900 people. more on Edwards Lifesciences
Edwards Lifesciences Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
Edwards Lifesciences SEC Filings
Edwards Lifesciences SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameEdwards Lifesciences Corporatio
ChairmanMichael MussallemView All
Thematic Classifications
Active investing themes Edwards Lifesciences currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
showing 2 out of 4 themes  View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Edwards Lifesciences
Piotroski F Score
Academic score to determine the current strength of Edwards Lifesciences financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
Edwards Lifesciences ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: BBB-Tolerable
Few selected profitability drivers of Edwards Lifesciences representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
Gross Margin
Profit Margin
Edwards Lifesciences Corporatio (EW) is traded on BATS Exchange in USA. It is located in One Edwards Way, Irvine, CA 92614, United States and employs 13,900 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with market capitalization of 44.74 B. Edwards Lifesciences is active under Healthcare sector as part of Medical Devices industry. The entity has 207.97 M outstanding shares of which 2.32 M shares are currently sold short in the market by investors with about 1.38 days to cover all shorted shares. EDWARDS LIFESCIEN reports about 934.3 M in cash with 540.15 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.49.
Check Edwards Lifesciences Probability Of Bankruptcy

Ownership Allocation (%)

Edwards Stock Price Odds Analysis

Odds Down 184.86HorizonTargetOdds Up 184.86
7.93%30 days
Based on normal probability distribution, the odds of Edwards Lifesciences to move above current price in 30 days from now is about 92.02 (This Edwards Lifesciences Corporatio probability density function shows the probability of Edwards Lifesciences Stock to fall within a particular range of prices over 30 days) .

Edwards Stock Top Holders

Edwards Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
Blackrock IncCommon Shares18.2 M4.2 B
Vanguard Group IncCommon Shares16.3 M3.8 B
View Edwards Lifesciences Diagnostics

Edwards Lifesciences Income Statement Over Time

Edwards Lifesciences Corporatio Income Statement is one of the three primary financial statements used for reporting Edwards's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Edwards Lifesciences revenue and expense. Edwards Lifesciences Income Statement primarily focuses on the company's revenues and expenses during a particular period. Edwards Lifesciences Direct Expenses is fairly stable at the moment as compared to the last year. Edwards Lifesciences reported Direct Expenses of 1.11 Billion in 2019. Income Tax Expense is likely to grow to about 148.7 M in 2020, whereas Consolidated Income is likely to drop slightly above 845.3 M in 2020. View More Fundamentals
Consolidated Income    Earning Before Interest and Taxes EBIT    Earning Before Interest and Taxes USD    

Edwards Stock Against Markets

Did you try this?

Run Sync Your Broker Now


Sync Your Broker

Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
All  Next Launch Module

Edwards Lifesciences Upcoming and Recent Events

Edwards Lifesciences Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportApril 28, 2020
Next Earnings ReportJuly 28, 2020
Next Fiscal Quarter EndMarch 31, 2020
Next Fiscal Year EndFebruary 4, 2021
Last Quarter Report DateDecember 31, 2019
Last Earning Anouncement DateMarch 31, 2019

Edwards Lifesciences Corporate Filings

Edwards Lifesciences SEC Reporting

Unclassified Corporate Event
Financial Statements and Exhibits. Results of Operations and Financial Condition
Other Events. Submission of Matters to a Vote of Security Holders

Edwards Lifesciences Corporate Directors

John Cardis Independent Director
Wesley Schack Presiding Independent Director
Nicholas Valeriani Independent Director
Continue to Investing Opportunities. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page